Suspendido

Influence of Central Venous and Abdominal Pressures on the Inferior Vena Cava Shape and Size

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está recopilando

Datos de Medicamento

Recopilados desde hoy en adelante - Prospectivo
Medicamento
Quiénes están siendo reclutados

Procesos Patológicos

+ Condiciones Patológicas, Signos y Síntomas

A partir de 18 años
+11 Criterios de eligibilidad
Ver todos los criterios de elegibilidad
Cómo está diseñado el estudio

Solo Casos

Examinando las características de las personas con una enfermedad para identificar factores genéticos o ambientales que contribuyen a la condición.
Observacional
Inicio del estudio: mayo de 2013
Ver detalles del protocolo

Resumen

Patrocinador PrincipalCatholic University of the Sacred Heart
Contacto del EstudioFranco Cavaliere, Prof.Más contactos
Última actualización: 7 de agosto de 2013
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Fecha de inicio: 1 de mayo de 2013

Fecha en la que se inscribió al primer participante.

The study will be carried out during the first 6 hours after the end of cardiac surgery when patients are mechanically ventilated and sedated with propofol and remifentanil to achieve a Ramsey sedation score of 3-4. The following four steps will be carried out: A) A baseline hemodynamic and ultrasound assessment with the head of the bed positioned at 30 °. B) The measurement of abdominal pressure with the head of the bed placed in a horizontal position for 3 minutes. C) A rapid fluid load test with the head of the bed raised again to be 30°. The test will be performed by infusing 250-300 mL/m2 Body Surface Area of 6% hydroxyethyl starch 6% 130/0.4 (VoluvenR) in 30 minutes and will be considered positive if the cardiac index increases by at least 15% above the baseline value. D) A second hemodynamic and ultrasound assessment with the head of the bed positioned at 30 °. Hemodynamic evaluation The hemodynamic assessment will be run out by evaluating heart rate, systemic arterial and pulmonary pressures, central venous pressure, and pulmonary wedge pressure. Cardiac output will be measured by the thermodilution technique; the mean of three measures will be taken; then cardiac index will be calculated by dividing the cardiac output by the body surface area. Ultrasound measurements IVC maximum and minimum diameters (which will be defined as anteroposterior and lateral) will be measured at the end of inspiration and of expiration at four levels: 1 cm after the confluence of the iliac veins At the confluence of the renal veins Immediately below the confluence of the hepatic veins Immediately above the confluence of the hepatic veins (also in long axis) At level 3 maximum and average blood velocity will be measured by Doppler provided that the angle of insonation is 60° or less. At each level, we will compute the ratio R between the anteroposterior and lateral diameters (eccentricity) and the sectional area, calculated with the formula for the ellipse. Statistical analysis The data obtained will be presented as mean (standard deviation). Statistical analysis will be performed with ANOVA for repeated measures and post-hoc comparisons with Student Newman Keuls test. ROC (Receiver Operating Characteristic) curves will be calculated to test the predictivity of a positive fluid load test by the aforementioned parameters; the analysis will be performed at the level at which each parameter shows the largest variations after the load test. The a priori power analysis was performed on the primary endpoint, i.e. on changes of R in relation to IVC levels and fluid volume test with the program Gpower (17). The analysis was carried out on ANOVA with a 4 x 2 design by assuming an α error of 0.05, a power of 1-β of 0.95, and an f of 0.40, which corresponded to a large-size effect. The index f is a standardized measure of the effect size and is equal to the minimum difference considered clinically relevant divided by the standard deviation in the population. Since, the standard deviation of R was 0.1 in a previous study on healthy volunteers, an f value of 0.4 corresponded to a minimal difference of 0.04 between R values. On this basis, we obtained 112 determinations over all groups of the design, which corresponded to a sample of 14 patients (112/8=14); such value was increased by 10%, and the final sample of 16 patients was obtained.

Patrocinador PrincipalCatholic University of the Sacred Heart
Contacto del EstudioFranco Cavaliere, Prof.Más contactos
Última actualización: 7 de agosto de 2013
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.
Detalles del Diseño

Se reclutarán 16 pacientes

Número total de participantes que el ensayo clínico espera reclutar.

Solo Casos

Estos estudios se centran únicamente en personas con una enfermedad específica. Se analizan patrones, frecuentemente genéticos o ambientales, para identificar posibles factores relacionados con la condición.

Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios

Cualquier sexo

Sexo biológico de los participantes elegibles para inscribirse.

A partir de 18 años

Rango de edades de los participantes que pueden unirse al estudio.

Voluntarios sanos no permitidos

Indica si personas sanas, sin la condición que se estudia, pueden participar.

Condiciones

Patología

Procesos PatológicosCondiciones Patológicas, Signos y Síntomas

Criterios

3 criterios de inclusión requeridos para participar
a condition of adequate sedation and good adaptation to mechanical ventilation

the need determined by the attending physician to perform a rapid fluid load test to guide infusions

the presence of an arterial catheter and a catheter in the pulmonary artery

8 criterios de exclusión impiden participar
administration of more than 1000 mL of hydroxyethyl starch in the last 24 hours

age < 18 years

bleeding from the surgical drains greater than 150 mL in the hour preceding the enrollment

hemodynamically significant right ventricular failure

Mostrar Más Criterios

Plan de Estudio

Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.
Objetivos del Estudio

Objetivos del Estudio

Objetivos Primarios

Objetivos Secundarios

Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.

Este estudio tiene una ubicación

Reclutando

Catholic University of the Sacred Heart

Rome, ItalyAbrir Catholic University of the Sacred Heart en Google Maps
Suspendido1 Centros de Estudio